Safety and immunogenicity of REMUNE™ in HIV-infected Thai subjects-Reference-Cited by-同舟云学术

Safety and immunogenicity of REMUNE™ in HIV-infected Thai subjects

Published:1998-01 Issue:2-3 Volume:16 Page:142-149
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Limsuwan Anuwat,Churdboonchart Vina,Moss Ronald B.,Sirawaraporn Worachart,Sutthent Reungpung,Smutharaks Buranaj,Glidden David,Trauger Richard,Theofan Georgia,Carlo Dennis

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference24 articles.

1. The Epidemic in Thailand;Cohen;Science,1994

2. Initial studies on active immunization of HIV infected subjects using a gp-120 depleted HIV-1 immunogen: long-term follow-up;Levine;J. AIDS,1996

3. Safety and immunogenicity of a gp120-depleted, inactivated HIV-1 immunogen: results of a double-blind adjuvant controlled trial;Trauger;J. AIDS Hum. Retrovirol.,1995

4. Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA, and percentage of CD4 cells;Trauger;J. Infect. Dis.,1994

5. Correlation of genetic and serologic approaches to HIV-1 subtyping in Thailand;Gaywee;J. AIDS Hum. Retrovirol.,1996

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-1 Immunogen: an overview of almost 30 years of clinical testing of a candidate therapeutic vaccine;Expert Opinion on Biological Therapy;2016-06-08

2. Can immunotherapy be useful as a “functional cure” for infection with Human Immunodeficiency Virus-1?;Retrovirology;2012-09-07

3. Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51;PLoS ONE;2008-07-09

4. Immunotherapy for Pregnant Women and Newborns;Annals of the New York Academy of Sciences;2006-01-25

5. Therapeutic HIV vaccines: An update;Current HIV/AIDS Reports;2005-03